|Bid||0.000000 x 800|
|Ask||0.000000 x 900|
|Day's Range||0.573000 - 0.580600|
|52 Week Range||0.520000 - 1.300000|
|Beta (3Y Monthly)||1.73|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 21, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.50|
LIVINGSTON, N.J., Nov. 19, 2018 -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise.
LIVINGSTON, N.J., Nov. 15, 2018 -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise.
A look at the shareholders of Milestone Scientific Inc (NYSEMKT:MLSS) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller, companies while huge Read More...
Milestone Scientific Inc. (MLSS) today announced a new clinical study published in the International Journal of Obstetric Anesthesia that finds the CompuFlo® Epidural System to be successful in objectively identifying the epidural space—even in difficult patients. Accurate epidural space identification can build physician and resident confidence while reducing the number of attempts, poor catheter placement and accidental dural punctures that can be costly to the hospital and painful for the patient.
Dr. Mark Hochman, D.D.S., Inventor and Clinical Director of Milestone Scientific, stated, “Our computer-controlled systems with proprietary DPS Dynamic Pressure Sensing technology® are designed to make all types of injections precise, efficient, and virtually painless. This patent will further expand our intellectual property portfolio into PNB procedures.
Kent Krafft, Vice President of Clinical Technology Inc., stated, “We are impressed with Milestone Scientific’s CompuFlo® Epidural System following extensive due diligence prior to entering this agreement. We have several instruments on loan with top anesthesiologists and have received positive feedback from both providers and patients, reinforcing our confidence in this disruptive technology. Knowing the precise location of a needle during an epidural procedure provides a measure of safety not available to medical professionals using conventional syringes that rely on subjective perception to identify the epidural space.
If you’re interested in Milestone Scientific Inc (NYSEMKT:MLSS), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock couldRead More...
NEW YORK, NY / ACCESSWIRE / August 15, 2018 / Milestone Scientific Inc. (NYSE MKT: MLSS ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 15, 2018 at 8:30 AM Eastern ...
LONDON, UK / ACCESSWIRE / May 16, 2018 / If you want access to our free research report on Milestone Scientific, Inc. (NYSE: MLSS), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=MLSS as the Company's latest news hit the wire. On May 14, 2018, the Company announced that it has inked an agreement with a leading Midwestern distributor and other distributors to promote the sale of CompuFlo® Epidural System in the United States. Active-Investors.com is currently working on the research report for BioLife Solutions, Inc. (NASDAQ: BLFS), which also belongs to the Healthcare sector as the Company Milestone Scientific.
Stock Monitor: Milestone Scientific Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 17, 2018 / Active-Investors.com has just released a free research report on Nxstage Medical, Inc. (NASDAQ: NXTM ...
Milestone Scientific Inc. , a leading developer of computerized drug instruments that provide painless and precise injections, today announced the appointment of Eric W. Gilbert as Vice President of US ...
Milestone Scientific Inc. , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results ...
Milestone Scientific Inc. , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 4:30 PM Eastern ...